The Langford Institute is a not-for-profit corporation that is associated with TTI and which is dedicated to advancing the science of drug delivery. The Institute reviews and funds pre-clinical and clinical research into applications of the TDS® technology and coordinates joint projects with academic and other not-for-profit and non-profit educational and research institutions around the world. TTI founder Kenneth Kirby is the Executive Director of the Institute.